Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06915220 · ClinicalTrials.gov registry record · NA

ADAPT Micro-Randomized Trial

A NA study of Cardiovascular Diseases, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06915220: Recruiting NA study of Cardiovascular Diseases, sponsored by University of Michigan.

NCT06915220 is a NA study of Cardiovascular Diseases that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 60 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06915220, a NA study of Cardiovascular Diseases, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to collect quantitative and qualitative data that can be used to optimize the HeartSteps mHealth intervention for physical activity. The current version of the intervention is intended to help patients with heart disease increase and maintain their physical activity long-term. To accomplish this goal, a 3-month pilot micro-randomized trial (MRT) will be conducted with 60 patients who are currently completing or have recently completed phase II cardiac rehabilitation (CR). The core of the study participation is the use of the HeartSteps intervention over the course of 3 months. This includes wearing the Fitbit Charge activity tracker during waking hours and using the HeartSteps intervention to support their efforts to be active. The HeartSteps intervention consists of two sets of intervention components: (1) components intended to improve participants' affective associations with physical activity, including activity suggestions designed to to trigger positive feelings and associate them with being active, and prompts to bring their awareness to intrinsically motivating aspects of being active; and (2) components that target reflective self-regulatory processes, including graphs for self-monitoring, prompts to plan activity, and weekly activity goals. How exactly, and how much, participants will use HeartSteps will not be prescribed since our goal is to understand naturalistic trajectory of engagement with the intervention.

Primary Outcome

The primary outcome of the study is number of weekly minutes of moderate to vigorous physical activity (MVPA), as assessed by the Fitbit Charge 6 activity tracker. Primary analysis will assess the difference in MVPA between the baseline week and the last (i.e. 12th) week of the study.

Conditions Studied

Interventions

  • BEHAVIORAL mobile health app

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-05-20
Est. Completion 2026-03
Phase NA
University of Michigan

1,327 total trials

What NCT06915220 shows while recruiting

NCT06915220 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which mobile health app is the first listed.

NCT06915220 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06915220 about?

NCT06915220 is a clinical study titled "ADAPT Micro-Randomized Trial". The goal of this study is to collect quantitative and qualitative data that can be used to optimize the HeartSteps mHealth intervention for physical activity. The current version of the intervention is intended to help patients with heart disease increase and maintain their physical activity long-te...

What is the current status of trial NCT06915220?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-05-20. Estimated completion is 2026-03.

What conditions does trial NCT06915220 study?

This clinical trial studies the following conditions: Cardiovascular Diseases.

What interventions are being tested in trial NCT06915220?

The interventions under investigation include: mobile health app (BEHAVIORAL).

Who is sponsoring clinical trial NCT06915220?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06915220 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06915220's enrollment target sits among peer trials

60 222nd of 300 higher than 69 of 300 other Cardiovascular Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06915220, the US trial registry maintained by the National Library of Medicine. NCT06915220 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.